These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [RHD genotyping from cell-free fetal DNA circulating in pregnant women peripheral blood and sensitivity assessment of innovated diagnostic approaches for introduction into the clinical practice]. Böhmová J; Vodička R; Lubušký M; Studničková M; Holusková I; Vrtěl R; Kratochvílová R; Frydrychová M; Krejčiříková E; Filipová H Ceska Gynekol; 2013 Jan; 78(1):32-40. PubMed ID: 23607381 [TBL] [Abstract][Full Text] [Related]
4. The effectiveness of KEL and RHCE fetal genotype assessment in alloimmunized women by minisequencing. Durdová V; Böhmová J; Kratochvílová T; Vodička R; Holusková I; Langová K; Lubušký M Ceska Gynekol; 2020; 85(3):164-173. PubMed ID: 33562967 [TBL] [Abstract][Full Text] [Related]
5. Determination of fetal RHD type in plasma of RhD negative pregnant women. Sørensen K; Kjeldsen-Kragh J; Husby H; Akkök ÇA Scand J Clin Lab Invest; 2018 Sep; 78(5):411-416. PubMed ID: 29869532 [TBL] [Abstract][Full Text] [Related]
6. Immunological principle of development of red blood cell alloimmunization in pregnancy, hemolytic disease of the fetus and prevention of RhD alloimmunization in RhD negative women. Roubalová L; Lubušký M Ceska Gynekol; 2020; 85(6):408-416. PubMed ID: 33711901 [TBL] [Abstract][Full Text] [Related]
8. Noninvasive Fetal RhD Blood Group Genotyping: A Health Technology Assessment. Ontario Health (Quality) Ont Health Technol Assess Ser; 2020; 20(15):1-160. PubMed ID: 33240456 [TBL] [Abstract][Full Text] [Related]
9. Routine administration of Anti-D: the ethical case for offering pregnant women fetal RHD genotyping and a review of policy and practice. Kent J; Farrell AM; Soothill P BMC Pregnancy Childbirth; 2014 Feb; 14():87. PubMed ID: 24568571 [TBL] [Abstract][Full Text] [Related]
11. Sensitivity of fetal RHD screening for safe guidance of targeted anti-D immunoglobulin prophylaxis: prospective cohort study of a nationwide programme in the Netherlands. de Haas M; Thurik FF; van der Ploeg CP; Veldhuisen B; Hirschberg H; Soussan AA; Woortmeijer H; Abbink F; Page-Christiaens GC; Scheffer PG; Ellen van der Schoot C BMJ; 2016 Nov; 355():i5789. PubMed ID: 27821701 [TBL] [Abstract][Full Text] [Related]
12. [Incidence of erythrocyte alloimmunization in pregnant women in olomouc region]. Holusková I; Lubušký M; Studničková M; Procházka M Ceska Gynekol; 2013 Jan; 78(1):56-61. PubMed ID: 23607383 [TBL] [Abstract][Full Text] [Related]
13. Prenatal screening service for fetal RHD genotyping to guide prophylaxis: the two-year experience of the Friuli Venezia Giulia region in Italy. Londero D; Merluzzi S; Dreossi C; Barillari G Blood Transfus; 2023 Mar; 21(2):93-99. PubMed ID: 35848630 [TBL] [Abstract][Full Text] [Related]
14. Standardization non-invasive fetal RHD and SRY determination into clinical routine using a new multiplex RT-PCR assay for fetal cell-free DNA in pregnant women plasma: results in clinical benefits and cost saving. Macher HC; Noguerol P; Medrano-Campillo P; Garrido-Márquez MR; Rubio-Calvo A; Carmona-González M; Martin-Sánchez J; Pérez-Simón JA; Guerrero JM Clin Chim Acta; 2012 Feb; 413(3-4):490-4. PubMed ID: 22133782 [TBL] [Abstract][Full Text] [Related]
15. Terminating Routine Cord Blood RhD Typing of the Newborns to Guide Postnatal Anti-D Immunoglobulin Prophylaxis Based on the Results of Fetal RHD Genotyping. Stensrud M; Bævre MS; Alm IM; Wong HY; Herud I; Jacobsen B; de Vos DDJA; Stjern HE; Sørvoll IH; Barane JB; Bagås TE; Rasmussen M; Ulvahaug N; Wamstad V; Tomter G; Akkök CA Fetal Diagn Ther; 2023; 50(4):276-281. PubMed ID: 37379821 [TBL] [Abstract][Full Text] [Related]
16. Non-invasive prenatal diagnosis of fetal RhD by using free fetal DNA. Gönenç G; Işçi H; Yiğiter AB; Hançer V; Büyükdoğan M; Güdücü N; Dünder I Clin Exp Obstet Gynecol; 2015; 42(3):344-6. PubMed ID: 26152007 [TBL] [Abstract][Full Text] [Related]
17. High-throughput, non-invasive prenatal testing for fetal rhesus D status in RhD-negative women: a systematic review and meta-analysis. Yang H; Llewellyn A; Walker R; Harden M; Saramago P; Griffin S; Simmonds M BMC Med; 2019 Feb; 17(1):37. PubMed ID: 30760268 [TBL] [Abstract][Full Text] [Related]
18. Accuracy of prenatal determination of RhD type status by polymerase chain reaction with amniotic cells. Lighten AD; Overton TG; Sepulveda W; Warwick RM; Fisk NM; Bennett PR Am J Obstet Gynecol; 1995 Oct; 173(4):1182-5. PubMed ID: 7485316 [TBL] [Abstract][Full Text] [Related]
19. Non-invasive fetal RHD exon 7 and exon 10 genotyping using real-time PCR testing of fetal DNA in maternal plasma. Hromadnikova I; Vechetova L; Vesela K; Benesova B; Doucha J; Kulovany E; Vlk R Fetal Diagn Ther; 2005; 20(4):275-80. PubMed ID: 15980640 [TBL] [Abstract][Full Text] [Related]